What is Biogen's revenue?

Biogen (BIIB) generated $10.0B in revenue over the trailing twelve months, up 0.3% year over year.

Is Biogen profitable?

Biogen reported $883.5M in net income over the trailing twelve months, a 8.8% net margin.

What are Biogen's profit margins?

Gross margin is 74.0% and operating margin is 22.9%, with a 8.8% net margin.

What is Biogen's earnings per share?

Biogen's diluted EPS over the trailing twelve months is $5.98.

Where does Biogen's income statement data come from?

Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Biogen BIIB Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q2 '26	Q1 '26	Q4 '25	Q3 '25	Q2 '25
Total revenue	$2.74B+3.4%	$2.48B+1.9%	$2.28B-7.1%	$2.53B+2.8%	$2.65B+7.3%
Total cost of revenue	$776.9M+28.4%	$661M+5.0%	$495.5M-15.1%	$674.4M+5.6%	$605M+10.8%
Gross profit	$1.96B-4.0%	$1.82B+0.8%	$1.78B-4.7%	$1.86B+1.8%	$2.04B+6.3%
Gross margin	71.6%-5.5pp	73.3%-0.8pp	78.3%+2.0pp	73.4%-0.7pp	77.1%-0.7pp
Research and development	$529.6M+32.7%	$539M+24.2%	$509.4M-4.3%	$436.1M-19.6%	$399M-22.4%
Selling, general and administrative	$709.7M+21.6%	$607.3M+6.1%	$682.5M+0.4%	$594.8M+1.1%	$583.8M+5.4%
Total costs & expenses	$2.6B+36.9%	$2.1B-0.9%	$2.34B+8.0%	$1.98B-1.9%	$1.9B+7.7%
Interest expense	$82.3M+13.4%	$67.6M+12.7%	——	$67.4M+12.7%	$72.6M+18.4%
Other income (expense), net	$3M+191%	-$1.1M-120%	-$317.6M+6.3%	$15.8M+2,075%	-$3.3M-65.0%
Income before income taxes	$132.4M-82.2%	$377.7M+21.4%	$0-100%	$557.3M+23.6%	$744M+6.5%
Income tax expense	$34.9M-68.0%	$58.2M-17.7%	$0-100%	$90.8M+45.3%	$109.2M-5.1%
Net income	$97.5M-84.6%	$319.5M+32.8%	$0-100%	$466.5M+20.1%	$634.8M+8.8%
Net margin	3.6%-20.4pp	12.9%+3.0pp	0%-10.9pp	18.4%+2.6pp	24%+0.3pp
Diluted earnings per share	$0.66-84.8%	$2.15+31.1%	$0.00-100%	$3.17+19.2%	$4.33+8.3%
EBITDA	$450.8M-55.4%	$649.7M+17.2%	$200.2M-57.9%	$826.9M+19.2%	$1.01B+10.0%
EBITDA margin	16.5%-21.7pp	26.2%+3.4pp	8.8%-10.6pp	32.6%+4.5pp	38.2%+0.9pp
EBIT	$214.7M-73.7%	$445.3M+20.0%	$0-100%	$624.7M+22.3%	$816.6M+7.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Biogen.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biogen's revenue?: Biogen (BIIB) generated $10.0B in revenue over the trailing twelve months, up 0.3% year over year.
Is Biogen profitable?: Biogen reported $883.5M in net income over the trailing twelve months, a 8.8% net margin.
What are Biogen's profit margins?: Gross margin is 74.0% and operating margin is 22.9%, with a 8.8% net margin.
What is Biogen's earnings per share?: Biogen's diluted EPS over the trailing twelve months is $5.98.
Where does Biogen's income statement data come from?: Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.